Summary
L-654,284 ((2R, 12bS)-N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]-furo[2,3-a]quinolizin-2-yl)-N-methyl-2-hydroxyethanesulfonamide), a potent and selective antagonist of the alpha2 adrenoceptor, was tritiated to high specific activity. Saturation binding to cell membrane suspensions obtained from calf cerebral cortex revealed a high affinity binding site (0.63 nM). Kinetics of association and dissociation were well represented by single exponential processes, and the equilibrium dissociation constant obtained from the ratio of rate constants agreed well with that found by saturation binding. A direct comparison of saturation binding revealed that the antagonist [3H]L-654,284 had roughly the same affinity for the alpha2 adrenoceptor as the agonist [3H]clonidine and eight times the affinity of the antagonist [3H]rauwolseine. The maximum receptor densities of these radioligands were not significantly different. Competition assays with a series of compounds of known receptor affinity revealed that [3H]L-654,284 selectively binds to a site with all of the characteristics expected of the alpha2 adrenoceptor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alabaster VA, Brett JM (1983) Different affinities of α2-adrenoceptor antagonists for [3H]-rauwolscine binding sites in brain and spleen membranes. Br. J Pharmacol 79:314
Asakura M, Tsukamoto T, Imafuku J, Matsui H, Ino M, Hasegawa K (1985) Quantitative analysis of rat brain α2-receptors discriminated by [3H]clonidine and [3H]rauwolscine. Eur J Pharmacol 106:141–147
Box GEP (1960) Fitting empirical data. Proc NY Acad Sci 86:792–816
Braunwalder A, Stone G, Lovell R (1981) Characterization of [3H]clonidine binding to two sites in calf brain membranes. J Neurochem 37:70–78
Broadhurst AM, Wylie MG (1986) A reassessment of the binding of [3H]rauwolscine to membranes from the rat cortex. Neuropharmacology 25:287–295
Bylund DB (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav 22:835–843
Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (K I) and the concentration of inhibitor which causes 50 percent inhibition (I 50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Cheung Y-D, Barnett DB, Nahorski SR (1982) [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptors. Eur J Pharmacol 84:79–85
Cheung Y-D, Barnett DB, Nahorski SR (1984) Interactions of endogenous and exogenous norepinephrine with alpha2 adrenoceptor binding sites in rat cerebral cortex. Biochem Pharmacol 33:1293–1298
Diop L, Dausse J-P, Meyer P (1983) Specific binding of [3H]rauwolscine to α2-adrenoceptors in rat cerebral cortex: Comparison between crude and synaptosomal plasma membranes. J Neurochem: 41:710–715
Draper NR, Smith H (1966) Applied regression analysis. Wiley, New York, p 71
Glossmann H, Presek P (1979) Alpha noradrenergic receptors in brain membranes: Sodium, magnesium and guanyl nucleotides modulate agonist binding. Naunyn-Schmiedeberg's Arch Pharmacol 306:67–73
Hill AV (1910) The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J Physiol 40:iv-vii
Hoffman BB, Lefkowitz RJ (1982) Agonist interactions with α-adrenergic receptors. J Cardiovasc Pharmacol 4:S14-S18
Kawahara RS, Bylund DB (1985) Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex. J Pharmacol Exp Ther 233:603–610
Leonard BE (1980) Pharmacological properties of some “second generation” antidepressant drugs. Neuropharmacology 19: 1175–1183
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
McPherson G, Beart P (1983) The selectivity of some ergot derivatives for α1 and α2-adrenoceptors of rat cerebral cortex. Eur J Pharmacol 91:363–369
Perry BD, U'Prichard DC (1981) [3H]Rauwolscine (α-yohimbine): A specific antagonist radioligand for brain α2-adrenergic receptors. Eur J Pharmacol 76:461–464
Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356
Pettibone DJ, Clineschmidt BV, Lotti VJ, Martin GE, Huff JR, Randall WC, Vacca JP, Baldwin JJ (1986) L-654,284 a new potent and selective α2-adrenoceptor antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 333:110–116
Pinder RM (1985) α2-Adrenoceptor antagonists as antidepressants. Drugs of the future 10:841–857
Randall WC, Baldwin JJ, Cresson EL, Tolman RL, Weppelman RM, Lyon TF (1983) Multiple central α2-adrenoceptors of avian mammalian species. Biochem Pharmacol 32:1933–1940
Rouot BM, U'Prichard DC, Snyder SH (1980) Multiple α2-noradrenergic receptor sites in rat brain: Selective regulation of high-affinity [3H]clonidine binding by guanine nucleotides and divalent cations. J Neurochem 34:374–384
Salama A, Lin L, Repp L, U'Prichard DC (1982) Magnesium reduces affinities of antagonists at rat cortex α2-adrenergic receptors labeled with 3H-clonidine: Evidence for heterogeneity of α2-receptor conformations with respect to antagonists. Life Sci 30:1305–1311
Snedecor GW, Cochran WG (1980) Statistical methods (7th ed) Iowa State University, Ames, Iowa, p 235
U'Prichard DC, Greenberg DA, Snyder SH (1977) Binding characteristics of a radiolabelled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol 13:454–473
U'Prichard DC, Snyder SH (1978) Guanyl nucleotide influences on 3H-ligand binding to α-noradrenergic receptors in calf brain membranes. J Biol Chem 253:3444–3452
U'Prichard DC, Snyder SH (1980) Interactions of divalent cations and guanine nucleotides at α2-noradrenergic receptor binding sites in bovine brain mechanisms. J Neurochem 34:385–394
Author information
Authors and Affiliations
Additional information
Send offprint requests to W. C. Randall at the above address
Rights and permissions
About this article
Cite this article
Randall, W.C., Huff, J.R., Vacca, J.P. et al. [3H]L-654,284 as a probe of the central alpha2 adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 338, 47–52 (1988). https://doi.org/10.1007/BF00168811
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168811